You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

Hydralazine hydrochloride; hydrochlorothiazide; reserpine - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for hydralazine hydrochloride; hydrochlorothiazide; reserpine and what is the scope of patent protection?

Hydralazine hydrochloride; hydrochlorothiazide; reserpine is the generic ingredient in twelve branded drugs marketed by Chartwell Rx, Ivax Sub Teva Pharms, Mylan, Watson Labs, Sandoz, Solvay, Sun Pharm Industries, Lederle, and Novartis, and is included in sixteen NDAs. Additional information is available in the individual branded drug profile pages.

Summary for hydralazine hydrochloride; hydrochlorothiazide; reserpine
US Patents:0
Tradenames:12
Applicants:9
NDAs:16
Clinical Trials: 1
DailyMed Link:hydralazine hydrochloride; hydrochlorothiazide; reserpine at DailyMed
Recent Clinical Trials for hydralazine hydrochloride; hydrochlorothiazide; reserpine

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
VA Office of Research and Development
US Department of Veterans Affairs

See all hydralazine hydrochloride; hydrochlorothiazide; reserpine clinical trials

US Patents and Regulatory Information for hydralazine hydrochloride; hydrochlorothiazide; reserpine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs RESERPINE, HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydralazine hydrochloride; hydrochlorothiazide; reserpine TABLET;ORAL 085549-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Sun Pharm Industries RESERPINE, HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydralazine hydrochloride; hydrochlorothiazide; reserpine TABLET;ORAL 088570-001 Apr 10, 1984 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Solvay RESERPINE, HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydralazine hydrochloride; hydrochlorothiazide; reserpine TABLET;ORAL 088376-001 Oct 28, 1983 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Watson Labs RESERPINE, HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydralazine hydrochloride; hydrochlorothiazide; reserpine TABLET;ORAL 087556-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Ivax Sub Teva Pharms HYDRALAZINE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE AND RESERPINE hydralazine hydrochloride; hydrochlorothiazide; reserpine TABLET;ORAL 084291-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.